Einloggen

Thematische Bibliographien / Emblica officinalis

Inhaltsverzeichnis

Zeitschriftenartikel
Dissertationen
Bücher
Buchteile
Konferenzberichte

Auswahl der wissenschaftlichen Literatur zum Thema „Emblica officinalis“

Autor: Grafiati

Veröffentlicht am 18. Mai 2024

Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an

Wählen Sie eine Art der Quelle aus:

Machen Sie sich mit den Listen der aktuellen Artikel, Bücher, Dissertationen, Berichten und anderer wissenschaftlichen Quellen zum Thema "Emblica officinalis" bekannt.

Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.

Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.

Zeitschriftenartikel zum Thema "Emblica officinalis"

1

Mirajkar, Dr Chaitali, und Dr Umesh Hambire. „Oral Health Benefits of Phyllanthus Emblica“. Middle East Research Journal of Dentistry 1, Nr. 1 (27.12.2021): 23–26. http://dx.doi.org/10.36348/merjd.2021.v01i01.004.

Der volle Inhalt der Quelle

Annotation:

Abstract: Phyllanthus emblica also known as Emblica officinalis belongs to the Euphorbiaceae family. It is also known as Indian gooseberry, emblic myrobalans, and Amla (in Hindi). It has anti-inflammatory, antioxidant, cryoprotective, antiaging, antidiabetic and hepatoprotective properties. The fruit of Amla is rich in vitamin C (ascorbic acid) and contains several bioactive phytochemicals. It also contains polyphenols such as ellagic acid, chebulinic acid, gallic acid, chebulagic acid, apeigenin, quercetin, corilagin, leutolin. It has antimicrobial and anti-ulcerative property. It is used for management of oral ulcers and periodontal diseases.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

2

Yadav Abhishek und Samanta Krishanu. „Formulation and evaluation of herbal ointment using Emblica officinalis extract“. World Journal of Advanced Research and Reviews 9, Nr. 2 (28.02.2021): 032–37. http://dx.doi.org/10.30574/wjarr.2021.9.2.0040.

Der volle Inhalt der Quelle

Annotation:

Herbal medicine prepare various part of plant are used like flower, leaves, seeds, root etc. Instead off an herbal drug is design as the alternative formulation for the external use in the form of ointment. For the medicinal use the herbal ointment apply externally on human body. The main aims of this research are preparation of herbal ointment from the Emblica officinalis plants the antibacterial activity. Under this research work, it is design as herbal ointment with the help of methanolic extract of Emblica officinalis and determines the anti-bacterial capacity on it. In vitro study the antibacterial activity of the methanolic extracts of dried leaves of Emblica officinalis are determine by using the Agar cup plate method versus different bacteria such as Staphylococcus aureus, Bacillus subtilis, Escherichia coli and Pseudomonas aeruginosa etc. By blending the methanolic extract of Emblica officinalis (10 % w/w) into aqueous cream we formulated herbal ointment. The emulsifying agent and simple ointment bases are added in above herbal ointment for increase the antibacterial effectiveness during in vitro evaluation. The herbal ointment is also better in comparison to a commercial brand of Gentamicin ointment. Emblica officinalis (Family Euphorbiaceae) are broadly used in traditional system of medicine throughout different part of India. It is used in the treatment of cold, anemia, dysentery, fever, gravel, sores. It is very important to standardize the plant part pharmacognostically for its utilization in different formulation. The current study deals with the determination of formulation and evaluation of herbal ointment using Emblica officinalis extract.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

3

Zulfiqar, Hadia, Sitwat Amna, Muhammad Suhail, Tayyaba Muzaffar, Javaid Iqbal und Saba Amjad. „ROLE OF EMBLICA OFFICINALIS IN COPPER INDUCED LIVER TOXICITY IN ADULT ALBINO RATS“. Pakistan Postgraduate Medical Journal 34, Nr. 04 (30.12.2023): 173–76. http://dx.doi.org/10.51642/ppmj.v34i04.489.

Der volle Inhalt der Quelle

Annotation:

Background: Copper (Cu) is an important heavy metal used widely in all industries. However, its toxicity on various organs is established. Emblica officinalis, commonly known as Amla, is a potential antioxidant and can prevent Cu induced hepatotoxicity. Objective: To evaluate the effects of Emblica officinalis extract on liver histology and Alanine Aminotransferase (ALT) levels after Cu induced toxicity on adult albino rats. Methods: This was an experimental study of 28 days duration. 36 adult male albino rats were divided into three groups of twelve animals each. Group A was control group in which rats were given 1.5 ml normal saline while group B rats were given CuSO4 200mg/kg b.w./day. Rats in Group C were given both CuSO4 (200mg/kg b.w/day) and Emblica officinalis fruit extract (300mg/kg bw/day). The agents were fed via orogastric tube for four weeks and rats were sacrificed 24 hours after administration of last dose. Results: Cu treated rats showed necrosis of hepatocytes and Increased serum ALT levels. Emblica officinalis co-treatment attenuated Cu-induced hepatic necrosis and variation in ALT levels. The difference among the groups was statistically significant with p-value <0.05. Conclusion: Emblica officinalis fruit extract improves liver function in Cu induced hepatotoxicity by limiting oxidative damage.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

4

Patel, Anandkumar M. „A Critical Review of Pandughni Vati“. Healer 3, Nr. 2 (19.03.2023): 5. http://dx.doi.org/10.51649/healer.135.

Der volle Inhalt der Quelle

Annotation:

Pandughni Vati(Anubhuta)contains eight Ayurvedic drugs i.e. Amalaki (Emblica officinalis), Bibhitaki (Terminalia bellerica), Shunthi (Zingiber officinale Roscoe.), Maricha (Piper nigrum Linn.) Pippali (Piper longum Linn), Katuki (Picrorhiza kurroa), Punarnava (Boerhavia diffusa Linn.) and Vidanga (Embelia ribes Burm.f.) as well as Bhavana Dravya like Kumari(Aloe vera Miller.), Punarnava (Boerhavia diffusa Linn.), Amalaki (Emblica officinalis) and Gaumutra (Cow’s Urine) as this Formulation Developed by AYUSH Department, Ministry of Health and Family welfare, Govt. of India (Anubhuta). Pandughni Vati(Anubhuta) has properties of Katu-Tikta Rasa, Laghu, Ruksha Guna, Ushna Virya and Katu Vipaka (pungent). The drug has several properties as anti-viral, anti-bacterial, imunomodulatory, hepato protective due to its various components. These properties make it an effective drug for various general and liver diseases.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

5

S, Tapade S., Punam P. Suryawanshi, Priti Mane, Priyanka Dappadwad, Rameshwar Sangle, Ramraje Lahade, Rutuja Tandle und Rutuja Bedre. „Pharmacological and Medicinal Important of Plant Phyllanthus Emblica Linn. (Syn.Emblica Officinalis), Indian Gooseberry“. International Journal for Research in Applied Science and Engineering Technology 11, Nr. 10 (31.10.2023): 1473–80. http://dx.doi.org/10.22214/ijraset.2023.56206.

Der volle Inhalt der Quelle

Annotation:

Abstract: The plant names phyllanthus emblica linn (Amla) are very precious gift of nature which have a vital role in health care. Nowadays, use of herbal product become most important for humans over the world. This drug is very useful for the treatment of disease. The most important part of this plant (phyllanthus emblica) is fruit. Phyllanthus emblica Linn. (syn. Emblica officinalis), commonly known as Indian gooseberry or amla, belongs to the family Euphorbiaceae. Though all parts of the plant are used for medicinal purposes, the fruits especially are found tremendous pharmacological applications. They are highly nutritious and form an important dietary source of vitamin C, amino acids, and minerals. Emblica Officinalis Plant is reported to have diverse Pharmacological actions like Adaptogenic Activity, Hepatoprotective Activity, Anti-Bacterial Activity, Anti-Hyperlipidemia Activity, Hypolipidemic Activity, Anti-Atherogenic Activity, Immunostimulatory Activity, Anti-oxidant Activity, Anti-Tumor Activity,Anti-Microbial Activity,Chondroprotective Activity, Analgesic Activity, Anti-Inflammatory Activity & AntiDiarreheal Activity. Emblica Officinalis plant is used in the treatments of various ailments. The diverse ailments like cancer, Atherosclerosis, Inflammation, Osteoporosis, Nuerological disorders, Hypertention and other infectious disorders.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

6

Deori, Chinmoyee, Swarnamoni Das und Sushanta Kumar Bordoloi. „Role of Emblica officinalis (amla) in the prophylaxis of hepatic injury by carbon tetrachloride (CCl4) in albino rats“. International Journal of Basic & Clinical Pharmacology 6, Nr. 8 (22.07.2017): 1992. http://dx.doi.org/10.18203/2319-2003.ijbcp20173284.

Der volle Inhalt der Quelle

Annotation:

Background: The objective of the study was to evaluate the hepatoprotective activity of fruits extract of Emblica officinalis on carbon tetrachloride induced hepatotoxicity in Albino rats. Liver is vulnerable to wide variety of metabolic, toxic, microbial, circulatory and neoplastic insults. The dominant primary diseases of the liver are viral hepatitis, alcoholic liver disease and hepatocellular carcinoma. Due to absence of reliable drugs management of liver ailments in the modern medicine, plants and natural products are providing to be good hepatoprotectants as evident from voluminous published work on their hepatoprotective potentials.Methods: The required amount of fresh fruits of Emblica officinalis was collected and dried at room temperature. The dried fruit ground into powdered and was prepared by percolation method using 95% ethanol. Acute oral toxicity test of the fruits extract was performed as per OECD 423 guidelines. Carbon tetrachloride was used as the hepatotoxin. Silymarin suspension 100mg was used as a standard drug in this study.Results: The study was carried out with an attempt to evaluate the hepatoprotective activity of Emblica officinalis in carbon tetrachloride induced hepatic injury in albino rats. The results were analysed by using one way ANOVA followed by Dunnett’s test and (p <0.05) was considered significant.Conclusions: The present study shows that the Emblica officinalis has significant hepatoprotective activity in rats with carbon tetrachloride induced liver injury. Emblica officinalis is a commonly used traditional herb, which is safe, cost effective and grows widely in India and used by different ethnic groups for various diseases. That is why Emblica officinalis, a commonly used natural herb, deserve further consideration in order to establish its potential as safe economical hepatoprotective agent.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

7

Mansoury, Manal. „A Review of the Antidiabetic, Antihyperlipidemic, and Related Metabolic Disorder Documented Activities of Emblic Fruits (Phyllanthus emblica L.)“. Journal of Complementary Medicine Research 14, Nr. 1 (2022): 1. http://dx.doi.org/10.5455/jcmr.2022.13.05.01.

Der volle Inhalt der Quelle

Annotation:

Diabetes is a risky metabolic chronic sickness that threatens the lives and health of individuals, families, and communities everywhere. Management of diabetes and related metabolic syndrome (MS) relies heavily on diet. There are reports of folk plants showing varying levels of antihyperglycemic activity. Phyllanthus emblica Linn (syn. Emblica officinalis) (often referred to Emblic, Indian gooseberry, or amla) is a perennial tree in the Euphorbiaceae family. Due to the high concentration of phenolic compounds, Emblic fruit may be considered a plant source of natural antioxidants. Numerous studies have demonstrated Emblic fruit’s benefits on humans and animals that are antihyperglycemic, anti-inflammatory, antihyperlipidemic, antibacterial, analgesic and antipyretic, adaptogenic, hepatoprotective, anticancer, antiulcerogenic, and antioxidant. This review provided an overview of the published scientific studies (experimental and clinical) that documented the potential antidiabetic and antihyperlipidemic benefits associated with consuming Emblic fruits. In addition, the possible activity regarding related metabolic syndrome and diabetes complications was assessed.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

8

Veeraraghavan, Vishnu Priya. „Antioxidant effects of Emblica officinalis and Zingiber officinalis on arsenic and lead induced toxicity on Albino rats“. Bioinformation 17, Nr. 2 (28.02.2021): 295–305. http://dx.doi.org/10.6026/97320630017295.

Der volle Inhalt der Quelle

Annotation:

It is of interest to document the effect of Emblica officinalis (E. officinalis) and Zingiber officinalae (Z. officinalae) leaf extract on reactive oxygen species, antioxidant potential changes in arsenic and lead-induced toxicity in male rats. We used 8 groups of adult male Wistar rats with 1 control group for this study. The animals were divided into Group I: Control and Group II: Lead and sodium arsenite induced rats (animals were induced for metal toxicity by the combined administration of arsenic (13.8 mg/kg body weight) and lead (116.4 mg/kg body weight). These doses were administered by gastric intubation during 14 consecutive days using known standard procedures. Arsenic and lead induced rats treated with ethanolic extract of Emblica officinalis (60 mg/kg body weight/day, orally for 45 days) are group III rats.Group IV animals are arsenic and lead induced rats treated orally with ethanolic extracts of E. officinalis (120 mg/kg body weight/day for 45 days). Group V animals are arsenic and lead induced rats treated orally with ethanolic extracts of Z. officinalae (60 mg/kg body weight/day for 45 days). Group VI animals are arsenic and lead induced rats orally treated with ethanolic extracts of Zingiber officinalis (120 mg/kg body weight/day for 45 days). Group VII animals are arsenic and lead induced rats treated orally with ethanolic extracts of E. officinalis and Z. officinalae (60 + 60 mg/kg body weight/day for 45 days). Group VIII animals are arsenic and lead induced rats treated orally with ethanolic extracts of E. officinalis and Z. officinalae (120 + 120 mg/kg body weight/day, orally for 45 days). Normal Control animals were treated orally with ethanolic extracts of E. officinalis (120mg/kg body weight) + Z. officinalae (120mg/kg body weight) for 45 days. The control and experimental animals were then subjected to analysis for oxidative stress markers such as H2O2, *OH, and lipid peroxidation (LPO), antioxidant enzymes in addition to liver and kidney function markers. Results: Arsenic and lead induced rats showed a significant increase in the levels of reactive oxygen species (H2O2, OH* and LPO) with concomitant alterations in the renal and liver tissues. However, enzymic and non-enzymic antioxidant levels were decreased. Nevertheless, an oral effective dose of E. officinalis and Z. officinalae (120 + 120 mg/kg body weight/day increased the antioxidant enzymes and retrieved the altered levels of ROS and LPO that were induced by arsenic and lead. Thus, we show that E. officinalis and Z. officinalae leaf extract exhibits nephroprotective and hepatoprotective role through the restoration of reactive oxygen species and antioxidant enzymes in the kidney and liver tissue of Arsenic and Lead-induced nephrotoxicity and hepatotoxicity in rats. Hence, E. officinalis and Z. officinalae leaf extract are potential therapeutic options for the treatment of metal toxicity-induced kidney and liver diseases.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

9

Vishnu Priya, Veeraraghavan. „Antioxidant effects of Emblica officinalis and Zingiber officinalis on arsenic and lead induced toxicity on Albino rats“. Bioinformation 17, Nr. 2 (28.02.2021): 295. http://dx.doi.org/10.6026//97320630017295.

Der volle Inhalt der Quelle

Annotation:

It is of interest to document the effect of Emblica officinalis (E. officinalis) and Zingiber officinalae (Z. officinalae) leaf extract on reactive oxygen species, antioxidant potential changes in arsenic and lead-induced toxicity in male rats. We used 8 groups of adult male Wistar rats with 1 control group for this study. The animals were divided into Group I: Control and Group II: Lead and sodium arsenite induced rats (animals were induced for metal toxicity by the combined administration of arsenic (13.8 mg/kg body weight) and lead (116.4 mg/kg body weight). These doses were administered by gastric intubation during 14 consecutive days using known standard procedures. Arsenic and lead induced rats treated with ethanolic extract of Emblica officinalis (60 mg/kg body weight/day, orally for 45 days) are group III rats.Group IV animals are arsenic and lead induced rats treated orally with ethanolic extracts of E. officinalis (120 mg/kg body weight/day for 45 days). Group V animals are arsenic and lead induced rats treated orally with ethanolic extracts of Z. officinalae (60 mg/kg body weight/day for 45 days). Group VI animals are arsenic and lead induced rats orally treated with ethanolic extracts of Zingiber officinalis (120 mg/kg body weight/day for 45 days). Group VII animals are arsenic and lead induced rats treated orally with ethanolic extracts of E. officinalis and Z. officinalae (60 + 60 mg/kg body weight/day for 45 days). Group VIII animals are arsenic and lead induced rats treated orally with ethanolic extracts of E. officinalis and Z. officinalae (120 + 120 mg/kg body weight/day, orally for 45 days). Normal Control animals were treated orally with ethanolic extracts of E. officinalis (120mg/kg body weight) + Z. officinalae (120mg/kg body weight) for 45 days. The control and experimental animals were then subjected to analysis for oxidative stress markers such as H2O2, *OH, and lipid peroxidation (LPO), antioxidant enzymes in addition to liver and kidney function markers. Results: Arsenic and lead induced rats showed a significant increase in the levels of reactive oxygen species (H2O2, OH* and LPO) with concomitant alterations in the renal and liver tissues. However, enzymic and non-enzymic antioxidant levels were decreased. Nevertheless, an oral effective dose of E. officinalis and Z. officinalae (120 + 120 mg/kg body weight/day increased the antioxidant enzymes and retrieved the altered levels of ROS and LPO that were induced by arsenic and lead. Thus, we show that E. officinalis and Z. officinalae leaf extract exhibits nephroprotective and hepatoprotective role through the restoration of reactive oxygen species and antioxidant enzymes in the kidney and liver tissue of Arsenic and Lead-induced nephrotoxicity and hepatotoxicity in rats. Hence, E. officinalis and Z. officinalae leaf extract are potential therapeutic options for the treatment of metal toxicity-induced kidney and liver diseases.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

10

Shuja, Naveed, Nabeela Zeeshan, Shahnaz Bano Memon, Asad Ali Zardari, Bakhtawar Mateen, Alina Saqib, Ihsan Ullah Khan und Arslan Shuja. „The Treatment of Hexavalent Chromium Induced Ovarian Cancer in Albino Rats with Emblica Officinalis. A Comparative Study“. Pakistan Journal of Medical and Health Sciences 16, Nr. 12 (31.12.2022): 450–53. http://dx.doi.org/10.53350/pjmhs20221612450.

Der volle Inhalt der Quelle

Annotation:

Background: Ovarian cancer may be treated with medicinal herbs like extract from Emblica officinalis Phytochemicals of this herb have antioxidant efficacy against oxidants and reduce cellular as well as genotoxicity. Aims and objectives: In current study hexavalent chromium induced ovarian cancer in albino rats were treated with emblica officinalis extract through a piolet project and measured its efficacy with the passage of time. Research Design: A comparative study of medicinal herbs, Emblica officinalis against ovarian cancer. Population Sampling: In this study female albino rates of about 100 gram body weight were selected comparatively. Sample Size: 15 female albino rates about equal weight were selected and divided them into different groups. Place and Duration: Present study was conducted from January 2022 to June 2022 at animal house of IMBB the University of Lahore and Biochemistry Department of Lahore Medical & Dental College Lahore Pakistan. Methodology: Total 15 female albino rates were selected in this study and divided them into different groups. In Group-A which is control all individuals were normal and not treated with anything. In Group-B and Group-C there were 5 rates in each group and they were treated with different strength of Emblica officinalis extract in distil water. Results: It has seen that the blood serum levels of CA-125, Alpha-fetoprotein and Lactate dehydrogenase in both group-B and group-C presented in table-2, table-3, table-4 and table-5 showed a remarkable significant changes (P≤0.05) after intervals of time. The significant changes in blood serum levels of CA-125, Alpha-fetoprotein and Lactate dehydrogenase (37±0.01, 42±0.01, 341±0.01) were noted in group-C individuals how were treated with 10mg/body weight ethanolic extract of Emblica officinalis for two month as compared to the control group-A. Practical implication Conclusion: The significant changes in blood serum levels of CA-125, Alpha-fetoprotein and Lactate dehydrogenase (37±0.01, 42±0.01, 341±0.01) were noted in group-C individuals how were treated with 10mg/body weight ethanolic extract of Emblica officinalis for two month as compared to the control group-A. Keywords: Alpha-fetoprotein, Lactate dehydrogenase, Emblica officinalis, Hexavalent Chromium

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Mehr Quellen

Dissertationen zum Thema "Emblica officinalis"

1

Agrawal, Krishna. „Stress ulcer: role of amlaki (emblica officinalis linn.)“. Thesis, University of North Bengal, 2002. http://hdl.handle.net/123456789/1041.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

2

Mitra, Prasanta Kumar. „Role of Amloki (Emblica officinalis linn) in experimental ulcer“. Thesis, University of North Bengal, 1987. http://hdl.handle.net/123456789/886.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

3

González, Jácome Yors Filiberto. „EFECTO DE UN POLIHERBAL (Emblica officinalis, Tinospora cordifolia y Withania somnífera) EN EL CONTEO DE COCCIDIAS Y VARIABLES PRODUCTIVAS DE CONEJOS EN FINALIZACIÓN“. Tesis de maestría, Universidad Autónoma del Estado de México, 2021. http://hdl.handle.net/20.500.11799/111849.

Der volle Inhalt der Quelle

Annotation:

El objetivo de la presente investigación fue evaluar el efecto de la inclusión de una formula poliherbal (Tinospora cordifolia, Withania somnifera y Emblica officinalis) sobre las variables productivas y la carga parasitaria de conejos alimentados con una ración de finalización.
El objetivo de la presente investigación fue evaluar el efecto de la inclusión de una formula poliherbal (Tinospora cordifolia, Withania somnifera y Emblica officinalis) sobre las variables productivas y la carga parasitaria de conejos alimentados con una ración de finalización. Siguiendo un diseño completamente al azar, se utilizaron 39 gazapos mixtos de 600 ± 70 g de peso vivo inicial, los cuales fueron divididos en tres tratamientos con 13 repeticiones. El experimento consistió en la adición de las siguientes dosis 0.0, 43.4 y 86.8 mg / animal / día que se proporcionó en forma de suspensión, por vía oral durante de cuatro semanas. Se determinaron los parámetros productivos además en las excretas se realizó el conteo de ooquistes de Eimerias spp. En la respuesta productiva se observó una diferencia significativa (P<0.05) para la variable de ganancia diaria de peso con un efecto lineal al aumentar la concentración de la formula poliherbal. Por otra parte el análisis de Eimeria spp. demostró una disminución en la prevalencia de ooquistes del 27.95 y 13.58 % por la adición del poliherbal en comparación con el testigo que mantuvo una prevalencia del 99.82 %. La diferencia en la presencia de ooquistes se observó desde el día 8 de aplicación, pero el día 16 presento el mayor efecto (P<0.05). Los resultados indican que la adición de la formula poliherbal puede ser una alternativa natural para el control de la coccidiosis en la producción de conejos.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Bücher zum Thema "Emblica officinalis"

1

Shiva, M. P. Myrobalans: Chebulic Myrobalan, Harra (terminalia chebula), Belliric Myrobalan, Bahera (terminalia bellirica), Emblic Myrobalan, Amla (emblica officinalis). Dehra Dun: Centre for Minor Forest Products, for Rural Development & Environmental Conservation, 2001.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

2

Tewari, Dina Nath. Phyllanthus Emblica Linn, Syn. Emblica Officinalis Gaertn ; Amla, Family : Euphorbiaceae. Ocean Books (P) Ltd., 2001.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Buchteile zum Thema "Emblica officinalis"

1

Dev, Sukh. „Emblica officinalis“. In Prime Ayurvedic Plant Drugs, 364–74. Cham: Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-22075-3_52.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

2

Khare, C. P. „Emblica officinalis Gaertn.“ In Indian Medicinal Plants, 1. New York, NY: Springer New York, 2007. http://dx.doi.org/10.1007/978-0-387-70638-2_565.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

3

Narayana, C. K. „Aonla (Phyllanthus emblica, Linn (syn.) Emblica officinalis Gaertn)“. In Phytochemicals in Fruits and their Therapeutic Properties, 17–25. London: CRC Press, 2021. http://dx.doi.org/10.1201/9781003245292-4.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

4

Narayana, C. K. „Aonla (Phyllanthus emblica, Linn (syn.) Emblica officinalis Gaertn)“. In Phytochemicals in Fruits and their Therapeutic Properties, 17–25. London: CRC Press, 2021. http://dx.doi.org/10.1201/9781003245292-4.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

5

Choudhary, Monika, und Kiran Grover. „Amla (Emblica officinalis L.) Oil“. In Fruit Oils: Chemistry and Functionality, 875–82. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-12473-1_48.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

6

Pal, Dilipkumar, und Souvik Mukherjee. „Role of Amla (Emblica officinalis) in Peptic Ulcer“. In Herbs, Spices, and Medicinal Plants for Human Gastrointestinal Disorders, 219–26. Boca Raton: Apple Academic Press, 2022. http://dx.doi.org/10.1201/9781003189749-18.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

7

Zanwar, Anand A., Sachin L. Badole und Rashmi Saini. „Role of Emblica officinalis in Prevention of Skin Disease“. In Bioactive Dietary Factors and Plant Extracts in Dermatology, 439–44. Totowa, NJ: Humana Press, 2012. http://dx.doi.org/10.1007/978-1-62703-167-7_40.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

8

Hussain, Syed Zameer, Bazila Naseer, Tahiya Qadri, Tabasum Fatima und Tashooq Ahmad Bhat. „Anola (Emblica officinalis): Morphology, Taxonomy, Composition and Health Benefits“. In Fruits Grown in Highland Regions of the Himalayas, 193–206. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-75502-7_15.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

9

Prajapati, R. K., C. S. Pandey, P. K. Gupta, V. K. Singh und S. R. Singh. „Recent Advances in Diseases Management of Aonla (Emblica officinalis)“. In Innovative Approaches in Diagnosis and Management of Crop Diseases, 365–407. New York: Apple Academic Press, 2021. http://dx.doi.org/10.1201/9781003187837-14.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

10

Maheshwari, S. K., Hare Krishna und Lokesh Kumar. „Aonla (Emblica Officinalis Gaertn.): Key Diseases and Their Management“. In Diseases of Horticultural Crops, 61–70. Boca Raton: Apple Academic Press, 2022. http://dx.doi.org/10.1201/9781003160397-3.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Konferenzberichte zum Thema "Emblica officinalis"

1

GOYAL, R. K., A. R. P. KINGSLY, PRADEEP KUMAR und HIMANSHU WALIA. „OSMOTIC DEHYDRATION OF AONLA (Emblica officinalis Gaertn)“. In The Proceedings of the 5th Asia-Pacific Drying Conference. World Scientific Publishing Company, 2007. http://dx.doi.org/10.1142/9789812771957_0153.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

2

Srivastava, Rachana, Poonam Khanna und Jaswinder Sangha. „Hypolipidemic Potential of Emblica officinalis (amla) Powder and Nutrition Counselling on Hyperlipidemic Subjects“. In Proceedings of the Third Andalas International Public Health Conference, AIPHC 2019, 10-11th October 2019, Padang, West Sumatera, Indonesia. EAI, 2020. http://dx.doi.org/10.4108/eai.9-10-2019.2297235.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

3

Gautam, K., S. Kumar, A. K. Singh, A. Ghosh und S. S. Manjangouda. „Emblica Officinalis-Based Hortipasture System for Environmental, Fodder and Nutritional Security in Semi-Arid Regions of India“. In XXV International Grassland Congress. Berea, KY 40403: International Grassland Congress 2023, 2023. http://dx.doi.org/10.52202/071171-0277.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

4

Sharma, Abhilasha, Dhanraj Soyal, Inder Singh, Nidhi Sharma und P. Goyal. „Abstract B68:Emblica officinalis, a citrus flavonone, protects against radiation-induced chromosomal damage in Swiss albino mice bone marrow“. In Abstracts: Frontiers in Cancer Prevention Research 2008. American Association for Cancer Research, 2008. http://dx.doi.org/10.1158/1940-6207.prev-08-b68.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

5

Boonfueang, Wanvisa, und Thitiwat Sriprasart. „Suppression of cough by Emblica officinalis extract, dextromethorphan versus placebo during endobronchial ultrasound bronchoscopy: a randomized double blind, double dummy, placebo-controlled trial“. In ERS International Congress 2021 abstracts. European Respiratory Society, 2021. http://dx.doi.org/10.1183/13993003.congress-2021.pa2453.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Wir bieten Rabatte auf alle Premium-Pläne für Autoren, deren Werke in thematische Literatursammlungen aufgenommen wurden. Kontaktieren Sie uns, um einen einzigartigen Promo-Code zu erhalten!